Industry News
What does the future hold for treating patients with locally advanced breast cancer?
Feb 28, 2015
Treating patients with locally advanced inoperable breast cancer is an extremely difficult task. Read More
One in 3 women could potentially be spared chronic pain after breast cancer surgery
Feb 28, 2015
One in every three women undergoing a mastectomy could potentially be spared chronic post-operative pain if anesthesiologists used a regional anesthetic technique in combination with standard care... Read More
What does the future hold for treating patients with locally advanced breast cancer?
Feb 28, 2015
Treating patients with locally advanced inoperable breast cancer is an extremely difficult task. Read More
One in 3 women could potentially be spared chronic pain after breast cancer surgery
Feb 28, 2015
One in every three women undergoing a mastectomy could potentially be spared chronic post-operative pain if anesthesiologists used a regional anesthetic technique in combination with standard care... Read More
Blood samples as surrogates for tumor biopsies in patients with lung cancer
Feb 27, 2015
A study examined the feasibility of using circulating free DNA (cfDNA) from blood samples of patients with advanced non-small-cell lung cancer as a surrogate for tumor biopsies to determine... Read More
Blood samples as surrogates for tumor biopsies in patients with lung cancer
Feb 27, 2015
A study examined the feasibility of using circulating free DNA (cfDNA) from blood samples of patients with advanced non-small-cell lung cancer as a surrogate for tumor biopsies to determine... Read More
Reasons for ibrutinib therapy discontinuation in patients with chronic lymphocytic leukemia
Feb 27, 2015
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during... Read More
MDs' recommendations on HPV vaccine carry weight with college students
Feb 27, 2015
College students say they would follow their doctor's recommendations concerning the human papillomavirus (HPV) vaccine, a currently underutilized opportunity for cancer prevention. Read More
Reasons for ibrutinib therapy discontinuation in patients with chronic lymphocytic leukemia
Feb 27, 2015
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during... Read More
MDs' recommendations on HPV vaccine carry weight with college students
Feb 27, 2015
College students say they would follow their doctor's recommendations concerning the human papillomavirus (HPV) vaccine, a currently underutilized opportunity for cancer prevention. Read More
Previous Page Next Page